ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

ADIL Adial Pharmaceuticals Inc

1.70
0.01 (0.59%)
Pre Market
Last Updated: 13:45:46
Delayed by 15 minutes
Share Name Share Symbol Market Type
Adial Pharmaceuticals Inc NASDAQ:ADIL NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.01 0.59% 1.70 1.69 1.73 2,094 13:45:46

Small Company Offering and Sale of Securities Without Registration (d)

17/06/2020 3:48pm

Edgar (US Regulatory)


o NoneEntity Type
0001513525
Adial Pharmaceuticals L.L.C.
ADial Pharmaceuticals, L.L.C.
Adial Pharmaceuticals, L.L.C.
 
x Corporation
o Limited Partnership
o Limited Liability Company
o General Partnership
o Business Trust
o Other
Name of Issuer
 ADIAL PHARMACEUTICALS, INC.
Jurisdiction of Incorporation/OrganizationDELAWARE 
Year of Incorporation/Organization
  o Over Five Years Ago
  x Within Last Five Years (Specify Year) 2017
  o Yet to Be Formed 



2. Principal Place of Business and Contact Information
Name of Issuer 
 ADIAL PHARMACEUTICALS, INC. 
Street Address 1Street Address 2
 1180 SEMINOLE TRAIL SUITE 495 
CityState/Province/CountryZIP/Postal CodePhone No. of Issuer
 CHARLOTTESVILLE VIRGINIA 22902 434-422-9800 



3. Related Persons
Last NameFirst NameMiddle Name
Stilley, IIIWilliamB.
Street Address 1Street Address 2
1180 Seminole Trail, Suite 495
CityState/Province/CountryZIP/Postal Code
CharlottesvilleVIRGINIA22902
Relationship: x Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
 

Last NameFirst NameMiddle Name
TruluckJosephM.
Street Address 1Street Address 2
1180 Seminole Trail, Suite 495
CityState/Province/CountryZIP/Postal Code
CharlottesvilleVIRGINIA22901
Relationship: x Executive Officer o Director o Promoter
Clarification of Response (if Necessary)
 

Last NameFirst NameMiddle Name
AndersonJamesK.
Street Address 1Street Address 2
1180 Seminole Trail, Suite 495
CityState/Province/CountryZIP/Postal Code
CharlottesvilleVIRGINIA22901
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
 

Last NameFirst NameMiddle Name
GillilandRobertsonH.
Street Address 1Street Address 2
1180 Seminole Trail, Suite 495
CityState/Province/CountryZIP/Postal Code
CharlottesvilleVIRGINIA22901
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
 

 
Last NameFirst NameMiddle Name
JohnsonBankoleA.
Street Address 1Street Address 2
1180 Seminole Trail, Suite 495
CityState/Province/CountryZIP/Postal Code
CharlottesvilleVIRGINIA22901
Relationship: x Executive Officer o Director o Promoter
Clarification of Response (if Necessary)
 

Last NameFirst NameMiddle Name
Newman, Jr.JamesW.
Street Address 1Street Address 2
1180 Seminole Trail, Suite 495
CityState/Province/CountryZIP/Postal Code
CharlottesvilleVIRGINIA22901
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
 

Last NameFirst NameMiddle Name
Schuyler, CFAKevin
Street Address 1Street Address 2
1180 Seminole Trail, Suite 495
CityState/Province/CountryZIP/Postal Code
CharlottesvilleVIRGINIA22901
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
 

Last NameFirst NameMiddle Name
GoodmanTony
Street Address 1Street Address 2
1180 Seminole Trail, Suite 495
CityState/Province/CountryZIP/Postal Code
CharlottesvilleVIRGINIA22901
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
 

 
Last NameFirst NameMiddle Name
ReichJackW.
Street Address 1Street Address 2
1180 Seminole Trail, Suite 495
CityState/Province/CountryZIP/Postal Code
CharlottesvilleVIRGINIA22901
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
 

 


4. Industry Group
o Agriculture Health Care o Retailing
 Banking & Financial Services   o Biotechnology o Restaurants
  o Commercial Banking   o Health Insurance Technology
  o Insurance  o Hospitals & Physicians  o Computers
  o Investing  x Pharmaceuticals  o Telecommunications
  o Investment Banking  o Other Health Care  o Other Technology
  o Pooled Investment Fund

    Travel
  o Other Banking & Financial Services o Manufacturing  o Airlines & Airports
 Real Estate  o Lodging & Conventions
  o Commercial  o Tourism & Travel Services
  o Construction  o Other Travel
  o REITS & Finance o Other
  o Residential 
  o Other Real Estate 
o Business Services 
 Energy 
  o Coal Mining 
  o Electric Utilities 
  o Energy Conservation 
  o Environmental Services 
  o Oil & Gas 
  o Other Energy 


5. Issuer Size
Revenue RangeAggregate Net Asset Value Range
o No Revenues o No Aggregate Net Asset Value
o $1 - $1,000,000 o $1 - $5,000,000
o $1,000,001 - $5,000,000 o $5,000,001 - $25,000,000
o $5,000,001 - $25,000,000 o $25,000,001 - $50,000,000
o $25,000,001 - $100,000,000 o $50,000,001 - $100,000,000
o Over $100,000,000 o Over $100,000,000
x Decline to Disclose o Decline to Disclose
o Not Applicable o Not Applicable


6. Federal Exemption(s) and Exclusion(s) Claimed (select all that apply)
o Rule 504(b)(1) (not (i), (ii) or (iii)) o Rule 505
o Rule 504 (b)(1)(i) x Rule 506(b)
o Rule 504 (b)(1)(ii) o Rule 506(c)
o Rule 504 (b)(1)(iii) o Securities Act Section 4(a)(5)
  o Investment Company Act Section 3(c)

7. Type of Filing
x New Notice Date of First Sale 2020-06-09 o First Sale Yet to Occur
o Amendment

8. Duration of Offering
Does the Issuer intend this offering to last more than one year? o Yes x No

9. Type(s) of Securities Offered (select all that apply)
o Pooled Investment Fund Interests x Equity
o Tenant-in-Common Securities o Debt
o Mineral Property Securities x Option, Warrant or Other Right to Acquire Another Security
x Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security o Other (describe)
  


10. Business Combination Transaction
Is this offering being made in connection with a business combination transaction, such as a merger, acquisition or exchange offer? o Yes x No
 
Clarification of Response (if Necessary) 
  

11. Minimum Investment
Minimum investment accepted from any outside investor$ 0 USD

12. Sales Compensation
RecipientRecipient CRD Number o None
 Maxim Group LLC 120708
(Associated) Broker or Dealer x None(Associated) Broker or Dealer CRD Number x None
    
Street Address 1Street Address 2
 THE CHRYSLER BUILDING 405 LEXINGTON AVENUE, 26TH FLOOR
City State/Province/CountryZIP/Postal Code
 NEW YORK NEW YORK 10174
State(s) of Solicitation o All States o Foreign/Non-US
 CALIFORNIA
 ILLINOIS
 NEW YORK
 

 



13. Offering and Sales Amounts
Total Offering Amount $ 5217000 USD o Indefinite
Total Amount Sold $ 5217000 USD 
Total Remaining to be Sold $ 0 USD o Indefinite
 
Clarification of Response (if Necessary)
 Combined purchase price of 2,820,000 shares of common stock (CS) in a registered direct offering & warrants in private placement to purchase 2,115,000 shares of CS with an exercise price of $2.00 per share.


14. Investors
o Select if securities in the offering have been or may be sold to persons who do not qualify as accredited investors,
Number of such non-accredited investors who already have invested in the offering
 
  Regardless of whether securities in the offering have been or may be sold to persons who do not qualify as accredited investors, enter the total number of investors who already have invested in the offering: 6


15. Sales Commissions & Finders’ Fees Expenses
Provide separately the amounts of sales commissions and finders' fees expenses, if any. If the amount of an expenditure is not known, provide an estimate and check the box next to the amount.
Sales Commissions$ 365190 USD x Estimate
Finders' Fees$ 0 USD o Estimate
 
Clarification of Response (if Necessary)
  


16. Use of Proceeds
Provide the amount of the gross proceeds of the offering that has been or is proposed to be used for payments to any of the persons required to be named as executive officers, directors or promoters in response to Item 3 above. If the amount is unknown, provide an estimate and check the box next to the amount.
 $ 0 USD o

1 Year Adial Pharmaceuticals Chart

1 Year Adial Pharmaceuticals Chart

1 Month Adial Pharmaceuticals Chart

1 Month Adial Pharmaceuticals Chart

Your Recent History

Delayed Upgrade Clock